Live
ePaper
Search
Home > Business > Novo Nordisk hikes 2026 outlook again as Wegovy pill beats forecasts

Novo Nordisk hikes 2026 outlook again as Wegovy pill beats forecasts

Written By:
Last Updated: November 4, 2026 16:02:33 IST

By Jacob Gronholt-Pedersen and Patrick Wingrove COPENHAGEN, Nov 4 (Reuters) – Obesity drugmaker Novo Nordisk raised its 2026 outlook for the third time this year on Wednesday as quarterly sales of its

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

MORE NEWS

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?